Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2012 | 06-2007 | 06-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 824 | N/A | N/A |
| Receivables | 184 | N/A | N/A |
| Other current assets | 87 | 0 | 0 |
| TOTAL | $1,095 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 53 | N/A | N/A |
| Intangibles | 1,672 | 0 | 0 |
| Other Non-Current Assets | 4 | 0 | 0 |
| TOTAL | $1,729 | $N/A | $N/A |
| Total Assets | $2,824 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 1,007 | N/A | N/A |
| Accounts payable and accrued liabilities | 118 | 0 | 0 |
| Accrued Expenses | 369 | N/A | N/A |
| TOTAL | $1,494 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 16 | N/A | N/A |
| Other Non-Current Liabilities | 80 | 0 | 0 |
| TOTAL | $96 | $N/A | $N/A |
| Total Liabilities | $1,590 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -43,436 | N/A | N/A |
| Other shareholders' equity | 32,524 | 0 | 0 |
| TOTAL | $1,234 | $N/A | $N/A |
| Total Liabilities And Equity | $2,824 | $0 | $0 |